vx has been researched along with oxotremorine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barak, D; Pittel, Z; Segall, Y | 1 |
| Grauer, E; Levy, A | 1 |
| Allon, N; Bloch-Shilderman, E; Egoz, I; Gilat, E; Grauer, E; Rabinovitz, I; Raveh, L; Weissman, BA | 1 |
| Ditargiani, RC; Doctor, BP; Genovese, RF; Johnson, CC; Saxena, A; Sun, W | 1 |
4 other study(ies) available for vx and oxotremorine
| Article | Year |
|---|---|
Function-specific blockage of M(1) and M(3) muscarinic acetylcholine receptors by VX and echothiophate.
Topics: Animals; Atropine; CHO Cells; Cholinesterase Inhibitors; Colforsin; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Echothiophate Iodide; Muscarinic Agonists; Muscarinic Antagonists; N-Methylscopolamine; Organothiophosphorus Compounds; Oxotremorine; Phosphatidylinositols; Protein Binding; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Transfection; Tritium | 2006 |
Oxotremorine-induced hypothermia as a method for evaluating long-term neuronal changes following poisoning by cholinesterase inhibitors in rats.
Topics: Aldicarb; Animals; Body Temperature; Carbamates; Central Nervous System; Cholinesterase Inhibitors; Disease Models, Animal; Hypothermia; Lethal Dose 50; Male; Muscarinic Agonists; Muscarinic Antagonists; N-Methylscopolamine; Organophosphorus Compounds; Organothiophosphorus Compounds; Oxotremorine; Peripheral Nervous System; Rats; Rats, Sprague-Dawley; Recovery of Function; Reproducibility of Results; Sarin; Seizures; Time Factors; Toxicity Tests | 2007 |
Subchronic exposure to low-doses of the nerve agent VX: physiological, behavioral, histopathological and neurochemical studies.
Topics: Animals; Behavior, Animal; Blood Cell Count; Blood Chemical Analysis; Blotting, Western; Body Weight; Brain; Brain Chemistry; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterases; Chronic Disease; Drug Implants; Male; Maze Learning; Muscarinic Agonists; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Oxotremorine; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Subcellular Fractions | 2008 |
Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats.
Topics: Animals; Butyrylcholinesterase; Chemical Warfare Agents; Cholinesterase Inhibitors; Humans; Motor Activity; Organothiophosphorus Compounds; Oxotremorine; Rats; Soman | 2010 |